PLX

PLX Operating Cash Flow (Statement)

$9.92MTTM · USD

Period ending:

PLX FY Cash from OperationsUSD
PLX FY Cash from Operations1996-12-31: -$40.57K1997-12-31: -$247.92K1998-12-31: -$909.52K1999-12-31: -$1.41M2000-12-31: -$53.11K2001-12-31: -$789.43K2002-12-31: -$146.59K2003-12-31: -$136.68K2004-12-31: -$168.13K2005-12-31: -$72.48K2006-12-31: -$5.09M2007-12-31: -$10.45M2008-12-31: -$16.02M2009-12-31: $44.45M2010-12-31: -$38.46M2011-12-31: -$23.57M2012-12-31: $635.00K2013-12-31: -$30.65M2014-12-31: -$29.28M2015-12-31: -$24.28M2016-12-31: -$32.10M2017-12-31: -$9.99M2018-12-31: -$7.74M2019-12-31: -$19.36M2020-12-31: -$26.11M2021-12-31: -$10.29M2022-12-31: -$25.00M2023-12-31: -$1.32M2024-12-31: $8.67M2025-12-31: -$11.99M$44.45M-$38.46M
1996-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PLX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 30 observations from Dec 31, 1996 to Dec 31, 2025.

Protalix Biotherapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-11,993,000
8,674,000
-1,318,000
-25,000,000
-10,285,000
-26,106,000
-19,358,000
-7,742,000
-9,994,000
-32,098,000
-24,284,000
-29,281,000
-30,653,000
635,000
-23,570,000
-38,464,000
44,452,000
-16,015,000
-10,449,000
-5,091,000
-72,475
-168,125
-136,682
-146,586
-789,428
-53,108
-1,408,137
-909,523
-247,920
-40,571

Compare operating cash flow (statement)

All PLX financial metrics · PLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.